Pharmosa Biopharm (ROCO:6875) FCF Margin % : -86,501.33% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Pharmosa Biopharm FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pharmosa Biopharm's Free Cash Flow for the three months ended in Mar. 2024 was NT$-64.9 Mil. Pharmosa Biopharm's Revenue for the three months ended in Mar. 2024 was NT$0.1 Mil. Therefore, Pharmosa Biopharm's FCF Margin % for the quarter that ended in Mar. 2024 was -86,501.33%.

As of today, Pharmosa Biopharm's current FCF Yield % is -0.60%.

The historical rank and industry rank for Pharmosa Biopharm's FCF Margin % or its related term are showing as below:

ROCO:6875' s FCF Margin % Range Over the Past 10 Years
Min: -19.24 Med: -12.41 Max: -12.41
Current: -19.24

During the past 6 years, the highest FCF Margin % of Pharmosa Biopharm was -12.41%. The lowest was -19.24%. And the median was -12.41%.

ROCO:6875's FCF Margin % is ranked better than
69.47% of 1045 companies
in the Biotechnology industry
Industry Median: -139.31 vs ROCO:6875: -19.24

Pharmosa Biopharm FCF Margin % Historical Data

The historical data trend for Pharmosa Biopharm's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmosa Biopharm FCF Margin % Chart

Pharmosa Biopharm Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-12.41

Pharmosa Biopharm Quarterly Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial									-	-	72.49	-	-86,501.33

Competitive Comparison of Pharmosa Biopharm's FCF Margin %

For the Biotechnology subindustry, Pharmosa Biopharm's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmosa Biopharm's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmosa Biopharm's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pharmosa Biopharm's FCF Margin % falls into.

Pharmosa Biopharm FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pharmosa Biopharm's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-39.045	/	314.5
	=	-12.41 %

Pharmosa Biopharm's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-64.876	/	0.075
	=	-86,501.33 %

Pharmosa Biopharm FCF Margin % Related Terms

Thank you for viewing the detailed overview of Pharmosa Biopharm's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmosa Biopharm (ROCO:6875) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.66, Sanchong Road, Nangang District, Taipei, TWN, 11502

Website

https://www.pharmosa.com.tw

Pharmosa Biopharm Inc is a world-class biotechnology company focusing on developing a new drug by exploiting proprietary formulation and manufacturing technology.

Pharmosa Biopharm (ROCO:6875) Headlines

No Headlines